Literature DB >> 31031387

Etiology and frequency of hospital admissions in maintenance hemodialysis patients in chronic kidney disease.

Jishu Deb Nath1, Abul Kashem1.   

Abstract

Chronic kidney disease (CKD) and end-stage renal disease are a global health problem worldwide. In developing countries, it is a particular challenge to deliver optimal hemodialysis (HD) due to prevailing socioeconomic conditions. This has multiple downstream effects, including frequent hospitalizations and increased morbidity. We conducted this retrospective study to identify the etiology of hospital admission in HD patients and to detect the duration and costs associated with their hospitalizations. A total of 42 maintenance HD patients were hospitalized during this time frame and their hospitalizations were studied for the purpose of this study. CKD is growing global public health problem causing socioeconomic impact. Hence, early detection and referral to nephrology services can reduce hospitalization rates after a planned dialysis start thus might improve patients' quality of life.

Entities:  

Year:  2019        PMID: 31031387     DOI: 10.4103/1319-2442.256858

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  3 in total

1.  Factors associated with quality of life among chronic kidney disease patients in Nepal: a cross-sectional study.

Authors:  Shambhu Kumar Saxena Mahato; Tawatchai Apidechkul; Pamornsri Sriwongpan; Rajani Hada; Guna Nidhi Sharma; Shravan Kumar Nayak; Ram Kumar Mahato
Journal:  Health Qual Life Outcomes       Date:  2020-06-29       Impact factor: 3.186

2.  Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury.

Authors:  Junjie Wang; Dongdong Fu; Soulixay Senouthai; Yanwu You
Journal:  Mol Med Rep       Date:  2019-10-09       Impact factor: 2.952

Review 3.  Epidemiology of haemodialysis outcomes.

Authors:  Aminu K Bello; Ikechi G Okpechi; Mohamed A Osman; Yeoungjee Cho; Htay Htay; Vivekanand Jha; Marina Wainstein; David W Johnson
Journal:  Nat Rev Nephrol       Date:  2022-02-22       Impact factor: 42.439

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.